Literature DB >> 19422265

Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery.

Jae-Seung Lee1, Jordan J Green, Kevin T Love, Joel Sunshine, Robert Langer, Daniel G Anderson.   

Abstract

The safe and effective delivery of RNA therapeutics remains the major barrier to their broad clinical application. Here we develop a new nanoparticulate delivery system based on inorganic particles and biodegradable polycations. First, gold nanoparticles were modified with the hydrophilic polymer poly(ethylene glycol) (PEG), and then small interfering RNA (siRNA) was conjugated to the nanoparticles via biodegradable disulfide linkages, with approximately 30 strands of siRNA per nanoparticle. The particles were then coated with a library of end-modified poly(beta-amino ester)s (PBAEs), previously identified as capable of facilitating intracellular DNA delivery. Nanoparticulate formulations developed here facilitate high levels of in vitro siRNA delivery, facilitating delivery as good or better than the commercially available lipid reagent, Lipofectamine 2000.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19422265      PMCID: PMC2728206          DOI: 10.1021/nl9009793

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  46 in total

1.  Hierarchical Pore Structures through Diatom Zeolitization We are grateful to BNFL, BOC, Engelhard, ICI, and EPSRC for financial support and to Richard Plaisted and James Forrest for providing the colloidal silicalite. We would also like to thank Micromeritics Ltd. for their help in obtaining the sorption and porosimetry data.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  2000-08-04       Impact factor: 15.336

Review 2.  siRNAs: applications in functional genomics and potential as therapeutics.

Authors:  Yair Dorsett; Thomas Tuschl
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

3.  Maximizing DNA loading on a range of gold nanoparticle sizes.

Authors:  Sarah J Hurst; Abigail K R Lytton-Jean; Chad A Mirkin
Journal:  Anal Chem       Date:  2006-12-15       Impact factor: 6.986

Review 4.  Strategies for silencing human disease using RNA interference.

Authors:  Daniel H Kim; John J Rossi
Journal:  Nat Rev Genet       Date:  2007-03       Impact factor: 53.242

5.  Layer-by-layer assembled gold nanoparticles for siRNA delivery.

Authors:  Asmaa Elbakry; Alaa Zaky; Renate Liebl; Reinhard Rachel; Achim Goepferich; Miriam Breunig
Journal:  Nano Lett       Date:  2009-05       Impact factor: 11.189

6.  Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles.

Authors:  David A Giljohann; Dwight S Seferos; Pinal C Patel; Jill E Millstone; Nathaniel L Rosi; Chad A Mirkin
Journal:  Nano Lett       Date:  2007-11-13       Impact factor: 11.189

7.  Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target.

Authors:  Dan Peer; Eun Jeong Park; Yoshiyuki Morishita; Christopher V Carman; Motomu Shimaoka
Journal:  Science       Date:  2008-02-01       Impact factor: 47.728

8.  A combinatorial library of lipid-like materials for delivery of RNAi therapeutics.

Authors:  Akin Akinc; Andreas Zumbuehl; Michael Goldberg; Elizaveta S Leshchiner; Valentina Busini; Naushad Hossain; Sergio A Bacallado; David N Nguyen; Jason Fuller; Rene Alvarez; Anna Borodovsky; Todd Borland; Rainer Constien; Antonin de Fougerolles; J Robert Dorkin; K Narayanannair Jayaprakash; Muthusamy Jayaraman; Matthias John; Victor Koteliansky; Muthiah Manoharan; Lubomir Nechev; June Qin; Timothy Racie; Denitza Raitcheva; Kallanthottathil G Rajeev; Dinah W Y Sah; Jürgen Soutschek; Ivanka Toudjarska; Hans-Peter Vornlocher; Tracy S Zimmermann; Robert Langer; Daniel G Anderson
Journal:  Nat Biotechnol       Date:  2008-04-27       Impact factor: 54.908

Review 9.  Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery.

Authors:  Dana J Gary; Nitin Puri; You-Yeon Won
Journal:  J Control Release       Date:  2007-05-26       Impact factor: 9.776

10.  Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque.

Authors:  Bao-jian Li; Qingquan Tang; Du Cheng; Chuan Qin; Frank Y Xie; Qiang Wei; Jun Xu; Yijia Liu; Bo-jian Zheng; Martin C Woodle; Nanshan Zhong; Patrick Y Lu
Journal:  Nat Med       Date:  2005-08-21       Impact factor: 53.440

View more
  80 in total

1.  Duplex end breathing determines serum stability and intracellular potency of siRNA-Au NPs.

Authors:  Pinal C Patel; Liangliang Hao; Weng Si Au Yeung; Chad A Mirkin
Journal:  Mol Pharm       Date:  2011-06-28       Impact factor: 4.939

2.  pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells.

Authors:  Hyejung Mok; Omid Veiseh; Chen Fang; Forrest M Kievit; Freddy Y Wang; James O Park; Miqin Zhang
Journal:  Mol Pharm       Date:  2010-09-14       Impact factor: 4.939

3.  Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles.

Authors:  Pinal C Patel; David A Giljohann; Weston L Daniel; Dan Zheng; Andrew E Prigodich; Chad A Mirkin
Journal:  Bioconjug Chem       Date:  2010-11-11       Impact factor: 4.774

4.  Sustained local delivery of siRNA from an injectable scaffold.

Authors:  Christopher E Nelson; Mukesh K Gupta; Elizabeth J Adolph; Joshua M Shannon; Scott A Guelcher; Craig L Duvall
Journal:  Biomaterials       Date:  2011-11-05       Impact factor: 12.479

5.  Surface-engineered nanomaterials as X-ray absorbing adjuvant agents for Auger-mediated chemo-radiation.

Authors:  Sang-Min Lee; De-Hao Tsai; Vincent A Hackley; Martin W Brechbiel; Robert F Cook
Journal:  Nanoscale       Date:  2013-06-21       Impact factor: 7.790

6.  Cationic lipid-coated gold nanoparticles as efficient and non-cytotoxic intracellular siRNA delivery vehicles.

Authors:  Won Ho Kong; Ki Hyun Bae; Sung Duk Jo; Jee Seon Kim; Tae Gwan Park
Journal:  Pharm Res       Date:  2011-08-13       Impact factor: 4.200

7.  Optimization of PAMAM-gold nanoparticle conjugation for gene therapy.

Authors:  Elizabeth R Figueroa; Adam Y Lin; Jiaxi Yan; Laureen Luo; Aaron E Foster; Rebekah A Drezek
Journal:  Biomaterials       Date:  2013-11-26       Impact factor: 12.479

8.  Triblock copolymer-encapsulated nanoparticles with outstanding colloidal stability for siRNA delivery.

Authors:  Jian Qian; Xiaohu Gao
Journal:  ACS Appl Mater Interfaces       Date:  2013-01-15       Impact factor: 9.229

9.  Selective inhibition of human brain tumor cells through multifunctional quantum-dot-based siRNA delivery.

Authors:  Jongjin Jung; Aniruddh Solanki; Kevin A Memoli; Ken-ichiro Kamei; Hiyun Kim; Michael A Drahl; Lawrence J Williams; Hsian-Rong Tseng; KiBum Lee
Journal:  Angew Chem Int Ed Engl       Date:  2010       Impact factor: 15.336

10.  Histone-Mimetic Gold Nanoparticles as Versatile Scaffolds for Gene Transfer and Chromatin Analysis.

Authors:  Erik V Munsell; Bing Fang; Millicent O Sullivan
Journal:  Bioconjug Chem       Date:  2018-10-29       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.